Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer

Por Farago, Anna F., Azzoli, Christopher G.
Publicado no Transl Lung Cancer Res (2017)

Current standards for clinical management of small cell lung cancer

Por Farago, Anna F., Keane, Florence K.
Publicado no Transl Lung Cancer Res (2018)

Crossover distribution and high interference for both the X chromosome and an autosome during oogenesis and spermatogenesis in Caenorhabditis elegans.

Por Meneely, Philip M, Farago, Anna F, Kauffman, Tate M
Publicado em 2002

Redefining the central serotonergic system based on genetic lineage

Por Jensen, Patricia, Farago, Anna F., Awatramani, Rajeshwar B., Scott, Michael M., Deneris, Evan S., Dymecki, Susan M.
Publicado em 2008

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one pr...

Por Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, Luis
Publicado no Future Oncol (2019)

CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES

Por Patel, Jyoti D, Farago, Anna F, Hong, David S, Lassen, Ulrik N, Leyvraz, Serge, Park, Keunchil, Sohal, Davendra P S, Solomon, Benjamin, Reeves, John A, Dima, Laura, Brega, Nicoletta, Drilon, Alexander
Publicado no Neuro Oncol (2020)

Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer–Transformed EGFR Mutant Non–Small-Cell Lung Cancer

Por Mooradian, Meghan J., Piotrowska, Zofia, Drapkin, Benjamin J., Dias-Santagata, Dora, Marcoux, Nicolas, Arnaoutakis, Konstantinos, Nagy, Rebecca J., Lanman, Richard, Iafrate, Anthony J., Farago, Anna F., Mino-Kenudson, Mari, Hata, Aaron N., Sequist, Lecia V.
Publicado no JCO Precis Oncol (2017)

Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses

Por Joshi, Nikhil S., Akama-Garren, Elliot H., Lu, Yisi, Lee, Da-Yae, Chang, Gregory P., Li, Amy, DuPage, Michel, Tammela, Tuomas, Kerper, Natanya R., Farago, Anna F., Robbins, Rebecca, Crowley, Denise M., Bronson, Roderick T., Jacks, Tyler
Publicado no Immunity (2015)

Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity

Por Dagogo-Jack, Ibiayi, Rooney, Marguerite, Lin, Jessica J., Nagy, Rebecca J., Yeap, Beow Y., Hubbeling, Harper, Chin, Emily, Ackil, Jennifer, Farago, Anna F., Hata, Aaron N., Lennerz, Jochen K., Gainor, Justin F., Lanman, Richard B., Shaw, Alice T.
Publicado no Clin Cancer Res (2019)

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY...

Por Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Jürgen, Govindan, Ramaswamy, Carbone, David P.
Publicado no Clin Cancer Res (2019)

The Art of Oncology: COVID‐19 Era

Por Reynolds, Kerry L., Klempner, Samuel J., Parikh, Aparna, Hochberg, Ephraim P., Michaelson, M. Dror, Mooradian, Meghan J., Lee, Richard J., Soumerai, Tara E., Hobbs, Gabriela, Piotrowska, Zofia, Sykes, David B., Farago, Anna F., Bardia, Aditya, Rosovsky, Rachel P., Ryan, David P.
Publicado no Oncologist (2020)

Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing

Por McFadden, David G., Papagiannakopoulos, Thales, Taylor-Weiner, Amaro, Stewart, Chip, Carter, Scott L., Cibulskis, Kristian, Bhutkar, Arjun, McKenna, Aaron, Dooley, Alison, Vernon, Amanda, Sougnez, Carrie, Malstrom, Scott, Heimann, Megan, Park, Jennifer, Chen, Frances, Farago, Anna F., Dayton, Talya, Shefler, Erica, Gabriel, Stacey, Getz, Gad, Jacks, Tyler
Publicado em 2014

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

Por Farago, Anna F., Le, Long P., Zheng, Zongli, Muzikansky, Alona, Drilon, Alexander, Patel, Manish, Bauer, Todd M., Liu, Stephen V., Ou, Sai-Hong I., Jackman, David, Costa, Daniel B., Multani, Pratik S., Li, Gary G., Hornby, Zachary, Chow-Maneval, Edna, Luo, David, Lim, Jonathan E., Iafrate, Anthony J., Shaw, Alice T.
Publicado no J Thorac Oncol (2015)

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer

Por Gainor, Justin F., Tseng, Diane, Yoda, Satoshi, Dagogo-Jack, Ibiayi, Friboulet, Luc, Lin, Jessica J., Hubbeling, Harper G., Dardaei, Leila, Farago, Anna F., Schultz, Katherine R., Ferris, Lorin A., Piotrowska, Zofia, Hardwick, James, Huang, Donghui, Mino-Kenudson, Mari, Iafrate, A. John, Hata, Aaron N., Yeap, Beow Y., Shaw, Alice T.
Publicado no JCO Precis Oncol (2017)

Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study

Por Lin, Jessica J., Zhu, Viola W., Schoenfeld, Adam J., Yeap, Beow Y., Saxena, Ashish, Ferris, Lorin A., Dagogo-Jack, Ibiayi, Farago, Anna F., Taber, Angela, Traynor, Anne, Menon, Smitha, Gainor, Justin F., Lennerz, Jochen K., Plodkowski, Andrew J., Digumarthy, Subba R., Ou, Sai-Hong Ignatius, Shaw, Alice T., Riely, Gregory J.
Publicado no J Thorac Oncol (2018)

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis

Por Gainor, Justin F., Shaw, Alice T., Sequist, Lecia V., Fu, Xiujun, Azzoli, Christopher G., Piotrowska, Zofia, Huynh, Tiffany, Zhao, Ling, Fulton, Linnea, Schultz, Katherine R., Howe, Emily, Farago, Anna F., Sullivan, Ryan J., Stone, James R., Digumarthy, Subba, Moran, Teresa, Hata, Aaron N., Yagi, Yukako, Yeap, Beow Y., Engelman, Jeffrey A., Mino-Kenudson, Mari
Publicado no Clin Cancer Res (2016)

Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an NTRK Gene Fusion

Por Farago, Anna F., Taylor, Martin S., Doebele, Robert C., Zhu, Viola W., Kummar, Shivaani, Spira, Alexander I., Boyle, Theresa A., Haura, Eric B., Arcila, Maria E., Benayed, Ryma, Aisner, Dara L., Horick, Nora K., Lennerz, Jochen K., Le, Long P., Iafrate, A. John, Ou, Sai-Hong I., Shaw, Alice T., Mino-Kenudson, Mari, Drilon, Alexander
Publicado no JCO Precis Oncol (2018)

Identification of DHODH as a therapeutic target in small cell lung cancer

Por Li, Leanne, Ng, Sheng Rong, Colón, Caterina I., Drapkin, Benjamin J., Hsu, Peggy P., Li, Zhaoqi, Nabel, Christopher S., Lewis, Caroline A., Romero, Rodrigo, Mercer, Kim L., Bhutkar, Arjun, Phat, Sarah, Myers, David T., Muzumdar, Mandar Deepak, Westcott, Peter M. K., Beytagh, Mary Clare, Farago, Anna F., Vander Heiden, Matthew G., Dyson, Nicholas J., Jacks, Tyler
Publicado no Sci Transl Med (2019)

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

Por Kodack, David P., Farago, Anna F., Dastur, Anahita, Held, Matthew A., Dardaei, Leila, Friboulet, Luc, von Flotow, Friedrich, Damon, Leah J., Lee, Dana, Parks, Melissa, Dicecca, Richard, Greenberg, Max, Kattermann, Krystina E., Riley, Amanda K., Fintelmann, Florian J., Rizzo, Coleen, Piotrowska, Zofia, Shaw, Alice T., Gainor, Justin F., Sequist, Lecia V., Niederst, Matthew J., Engelman, Jeffrey A., Benes, Cyril H.
Publicado no Cell Rep (2017)

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Por Marcoux, Nicolas, Gettinger, Scott N., O’Kane, Grainne, Arbour, Kathryn C., Neal, Joel W., Husain, Hatim, Evans, Tracey L., Brahmer, Julie R., Muzikansky, Alona, Bonomi, Philip D., del Prete, Salvatore, Wurtz, Anna, Farago, Anna F., Dias-Santagata, Dora, Mino-Kenudson, Mari, Reckamp, Karen L., Yu, Helena A., Wakelee, Heather A., Shepherd, Frances A., Piotrowska, Zofia, Sequist, Lecia V.
Publicado no J Clin Oncol (2019)